ANAPTYSBIO, INC — Director's Dealing 2017

Jan 26, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-01-25

Reporting Person: Avalon Ventures VII L P (10% Owner)
Reporting Person: Kinsella Kevin J (10% Owner)
Reporting Person: Tomlin Stephen Lawrence (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2036932	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock (right to buy)	$4.55	2018-11-04	Common Stock (117483)		Direct

Footnotes

F1: The general partner of Avalon Ventures VII, L.P. is Avalon Ventures VII GP, LLC. The managing members of Avalon Ventures VII GP, LLC are Kevin J. Kinsella and Stephen L. Tomlin.

F2: This warrant is exercisable at any time.